Evidence map›Paper›PMID 42467091›Full record

ArticleAnalytical and bioanalytical chemistry2026

Development and validation of a multi-matrix LC-MS/MS method for quantification of 20 drugs in human postmortem and porcine surrogate matrices.

Jeroen Roosendaal, Shirley Verschoor, Daan J Touw, Dick-Paul Kloos, Rogier van der Hulst

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jeroen RoosendaalTeam Toxicology, Department of Special Services and Expertise, Netherlands Forensic Institute, Laan Van Ypenburg 6, 2497 GB, The Hague, The Netherlands. j.roosendaal@nfi.nl.ORCID http://orcid.org/0000-0003-1750-7281
Shirley VerschoorTeam Toxicology, Department of Special Services and Expertise, Netherlands Forensic Institute, Laan Van Ypenburg 6, 2497 GB, The Hague, The Netherlands.
Daan J TouwDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Dick-Paul KloosTeam Toxicology, Department of Special Services and Expertise, Netherlands Forensic Institute, Laan Van Ypenburg 6, 2497 GB, The Hague, The Netherlands.
Rogier van der HulstTeam Toxicology, Department of Special Services and Expertise, Netherlands Forensic Institute, Laan Van Ypenburg 6, 2497 GB, The Hague, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alternative matrices are increasingly used in postmortem toxicology when conventional specimens such as femoral blood are unavailable. However, quantitative multi-matrix methods covering a wide range of tissues remain limited. This study describes the development and fit-for-purpose validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification of 20 forensically relevant drugs in human and porcine postmortem matrices. Analytes and internal standards were extracted by methanol-based protein precipitation, followed by reversed-phase chromatography gradient separation and quantitation using a linear ion trap consisting of a quadrupole mass filter. A solvent calibration curve was used to analyze all matrices in a single analytical run. Validation was performed according to a modified fit-for-purpose approach focusing on accuracy, precision, selectivity, carry-over, matrix effect, dilution feasibility, and stability. Acceptance criteria were fulfilled for 89.3% of analyte-matrix combinations under standard criteria and 96.7% after predefined fit-for-purpose adjustments. Porcine matrices showed analytical performance comparable to human tissues, supporting their use as surrogate matrices for method development and validation. The developed LC-MS/MS method enables quantification of drugs across a broad range of alternative postmortem matrices using a single extraction and calibration approach. The method is intended for fast, reliable, and resource-efficient multi-matrix studies rather than absolute quantification in individual matrices and provides a practical tool for the investigation of postmortem redistribution processes.

Indexed as

Liquid Chromatography-Mass SpectrometryTandem Mass SpectrometryAnimalsChromatography, LiquidForensic ToxicologyHumansPharmaceutical PreparationsReproducibility of ResultsSwinePharmaceutical PreparationsAlternative matricesForensic toxicologyLC–MS/MSPostmortem

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.